National Institute on Drug Abuse
Overview
The National Institute on Drug Abuse (NIDA) is a United States federal government research institute under the National Institutes of Health that supports and conducts scientific research on drug use and addiction.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Delix Therapeutics | Dec 2023 | Grant | Lead |
| Gilgamesh Pharma Inc. | Mar 2024 | Grant | Co-investor |
| Pirouette Pharma | Sep 2021 | Grant | Co-investor |
| Aphios Corporation | Sep 2015 | Grant | Co-investor |
| WayBetter | Apr 2020 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is National Institute on Drug Abuse based?
National Institute on Drug Abuse is headquartered in Bethesda, Maryland, United States.
When was National Institute on Drug Abuse founded?
National Institute on Drug Abuse was founded in 1974.
How many portfolio companies does National Institute on Drug Abuse have?
National Institute on Drug Abuse has 65 portfolio companies in Caplight's dataset.
What are some companies in National Institute on Drug Abuse's portfolio?
Portfolio companies visible on Caplight include Delix Therapeutics, Gilgamesh Pharma Inc., Pirouette Pharma, Aphios Corporation, WayBetter.
What was National Institute on Drug Abuse's most recent investment shown here?
National Institute on Drug Abuse's most recent investment in this portfolio sample was in Gilgamesh Pharma Inc. in 2024.
What sectors does National Institute on Drug Abuse focus on?
National Institute on Drug Abuse focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Mobility, Transportation & Logistics, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Consumer & Commerce, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Enterprise Software, Frontier & Industrial Tech, Enterprise Software.
What company stages does National Institute on Drug Abuse focus on?
National Institute on Drug Abuse typically invests at the MultiStage stage.
What is National Institute on Drug Abuse's AUM?
National Institute on Drug Abuse's assets under management are estimated between $1.7B and $2.0B.